June 6, 2017

Verseon Corporation (“Verseon” or the “Company”)

Transaction in Own Shares and Total Voting Rights

FREMONT, Calif.—Verseon, a technology-based pharmaceutical company, announces that on June 5, 2017 the Company purchased 42,917 Common Shares in the Company (the “Shares”) for an aggregate price of $10,729.25 (the “Transaction”) from former option holders in accordance with the terms and conditions of the Company’s 2007 Option Plan (the “2007 Plan”). Following the Transaction, the Shares will be held in treasury.

Pursuant to the 2007 Plan, during their services to the Company, option holders may elect to exercise options prior to their full vesting, with the Company retaining the right to repurchase any unvested shares at the original purchase price at the completion of the option holders’ service.

Total Voting Rights

Following the Transaction, the issued share capital of the Company will consist of 151,452,891 Common Shares and the Company will hold 42,917 shares in treasury. Therefore, the total number of Common Shares in the Company with voting rights will be 151,409,974. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.


For further information please contact:

Verseon Corporation
Tina Schlafly +1 (510) 225 9000
Cenkos (NOMAD and Joint Broker)  
Neil McDonald / Beth McKiernan +44 (0) 20 7397 8900
Cantor Fitzgerald Europe (Joint Broker)  
Marc Milmo / Phil Davies / Callum Butterfield +44 (0) 20 7894 7000
Mirabaud Securities LLP (Joint Broker)  
Peter Krens +44 (0) 20 7321 2508

For financial and business media enquiries, please contact

Buchanan Communications Ltd (PR Advisors)
Henry Harrison-Topham / Jamie Hooper +44 (0) 20 7466 5000

Our pledge

Verseon is committed to growth through innovation, building value for its shareholders while respecting its responsibilities as a good corporate citizen